Corrigendum: MicroRNAs: Potential mediators between particulate matter 2.5 and Th17/Treg immune disorder in primary membranous nephropathy

Xiaoshan Zhou; Haoran Dai; Hanxue Jiang; Hongliang Rui; Wenbin Liu; Zhaocheng Dong; Na Zhang; Qihan Zhao; Zhendong Feng; Yuehong Hu; Fanyu Hou; Yang Zheng; Baoli Liu

doi:10.3389/fphar.2023.1166591

Corrigendum: MicroRNAs: Potential mediators between particulate matter 2.5 and Th17/Treg immune disorder in primary membranous nephropathy

Front Pharmacol. 2023 Feb 27:14:1166591. doi: 10.3389/fphar.2023.1166591. eCollection 2023.

Authors

Xiaoshan Zhou^{1

2}, Haoran Dai³, Hanxue Jiang², Hongliang Rui^{2

4}, Wenbin Liu⁵, Zhaocheng Dong¹, Na Zhang⁶, Qihan Zhao^{2

6}, Zhendong Feng⁷, Yuehong Hu^{2

6}, Fanyu Hou⁸, Yang Zheng², Baoli Liu²

Affiliations

¹ Beijing University of Chinese Medicine, Beijing, China.
² Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China.
³ Shunyi Branch, Beijing Hospital of Traditional Chinese Medicine, Beijing, China.
⁴ Beijing Institute of Chinese Medicine, Beijing, China.
⁵ School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China.
⁶ School of Traditional Chinese Medicine, Capital Medical University, Beijing, China.
⁷ Pinggu Hospital, Beijing Hospital of Traditional Chinese Medicine, Beijing, China.
⁸ School of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, China.

Abstract

[This corrects the article DOI: 10.3389/fphar.2022.968256.].

Keywords: PLA2R1; PM2.5; Th17/Treg; microRNA; primary membranous nephropathy (PMN).

Publication types

Published Erratum

Grants and funding

This work is supported by grants from Capital’s Funds for Health Improvement and Research (No. 2020-2-2234 to BL), the National Key Research and Development Project of China (No. 2019YFC1709402 to BL), the General project of the National Natural Science Foundation of China (No. 81973793 to BL), and Youth Foundation of National Natural Science Foundation of China (No. 82004269 to HD).